New board members in Panion

Report this content

Communication from the Extraordinary General Meeting in Panion Animal Health AB held on the of August 2019.

Panion’s EGM decided to adopt the proposals to make changes in the board and appointed auditors as presented in the attached communications (English and Swedish).

The new board consists of Arne Ferstad, Jan Nilsson, and Lars Thunberg.

The board has held a constitutional meeting and appointed Arne Ferstad as chairman of the board.

Read more in attached documents

Anja E. H. Holm, CEO
+ 45-22 94 66 00

Bolaget ska utveckla och kommersialisera genterapi för behandling av epilepsiliknande tillstånd hos hundar och andra djur, samt utveckla och kommersialisera andra veterinärmedicinska produkter och nya behandlingsformer som kan ge sjuka djur bättre livskvalitet.
Panion will develop and commercialize a gene therapy treatment for dogs with drug refractory epilepsy, and other new animal health products and treatments that improve the quality of life for animals suffering from chronic diseases.